Navigation Links
Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting
Date:3/28/2009

mal storage disorders, which are severe, chronic genetic diseases with unmet medical needs.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as, but not limited to, "look forward to," "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "should" and "could," and similar expressions or words identify forward-looking statements. Such forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. The inclusion of forward-looking statements should not be regarded as a representation by Amicus that any of its plans will be achieved. Any or all of the forward-looking statements in this press release may turn out to be wrong. They can be affected by inaccurate assumptions Amicus might make or by known or unknown risks and uncertainties. For example, with respect to statements regarding the goals, progress, timing and outcomes of ongoing discussions with regulatory authorities and the potential goals, progress, timing and results of clinical trials, actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the business of Amicus, including, without limitation: the potential inability to reach final agreement with regulatory agencies on the use of a surrogate endpoint and phase 3 trial design for Amigal, the potential that the interim results of the phase 2 extension study may not be predictive of the final results of the study, the potential that results of clinical or pre-clinical studies indicate that the product candidates are unsafe or ineffective; and, our dependence on third parties in the conduct of our clinical studies. Further, the results of earlier clinical trials may not be predictive of future results. Additionally, al
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Amicus Therapeutics to Present at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
2. Amicus Therapeutics Announces Change to Board of Directors
3. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
4. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
5. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
6. Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference
7. Amicus Therapeutics Announces Third Quarter 2008 Financial Results
8. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
9. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
10. Amicus Therapeutics Opens Research Facility in San Diego
11. Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... A study has been launched to test whether technology ... help to tackle the problem of obesity.  This unique healthcare ... based in Stowmarket) and academics at University Campus Suffolk is ... which is inspired by equipment used to collect data about ...
(Date:1/15/2014)... 2014 DTS Language Services, Inc . ... Portal for Life Science organizations who need document translations. ... matter of their documents in advance with a selection of ... of translations, often a critical factor in clinical and scientific ...
(Date:1/15/2014)... , Jan. 15, 2014 TaiGen Biotechnology Company, Limited ... agreement with R-Pharm, a leading Russian pharmaceutical company, to ... Russian Federation , Turkey ... States (CIS). Nemonoxacin is a novel antibiotic for the treatment ...
(Date:1/14/2014)... Communications, a leading provider of strategic communications services to corporations and ... the United States and Europe ... JD, is returning to the firm,s Washington, D.C. ... more than two years of service as Associate Commissioner for the ...
Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Former FDA Associate Commissioner Returns To 3D Communications 2
... are the words of the automated announcement that one used ... whenever the doors opened. The gap refers to the space ... through the American workplace today, I cant help thinking that ... the country. In this case, the gap to watch out ...
... The Milwaukee Brewers will soon have ... players at Miller Park, officials announced Thursday. , ,Eastman ... will provide a Directview CR 850 computer-operated ... will be used to generate high-resolution digital X-rays of ...
... award from Raj Veeramani, director of the E-Business Institute. ... is a brave new world of advertising, says Jerry Shereshewsky, ... University of Wisconsin student (and cohort of former Madison Mayor ... his impact on the future of business. He was a ...
Cached Biology Technology:Minding the Generation Gap 2Minding the Generation Gap 3Advertising ambassador explains the reinvention of marketing 2Advertising ambassador explains the reinvention of marketing 3
(Date:4/20/2014)... growing in importance for both basic researchers and ... the University of Maryland have developed a new ... gene activity from RNA sequencing (RNA-seq) data., With ... speedy fish, estimates of gene expression that previously ... few minutes, with accuracy that equals or exceeds ...
(Date:4/20/2014)... corn crop residue to make ethanol and other biofuels ... than gasoline, according to a study published today in ... findings by a University of Nebraska-Lincoln team of researchers ... to meet federal mandates to ramp up ethanol production ... the stalks, leaves and cobs in cornfields after harvest ...
(Date:4/18/2014)... the past 20 years, researchers have published soil organic ... have suggested that soil organic carbon can be sequestered ... to no-till systems. However, there is a growing body ... and soybean rotations without cover crops, small grains, and ... at the published rates. , "Some studies have shown ...
Breaking Biology News(10 mins):Computational method dramatically speeds up estimates of gene expression 2Study casts doubt on climate benefit of biofuels from corn residue 2Study casts doubt on climate benefit of biofuels from corn residue 3Researchers question published no-till soil organic carbon sequestration rates 2Researchers question published no-till soil organic carbon sequestration rates 3Researchers question published no-till soil organic carbon sequestration rates 4
... Carnegie Mellon University,s M. Granger Morgan will unveil a ... can help society reduce dangerous greenhouse gas emissions and ... 9 at 1 p.m. at 1200 New York Ave. ... heads a team of investigators from Carnegie Mellon, the ...
... Philadelphia, PA As children transition from preschool-age to ... that may not meet current recommendations and may contribute ... January/February 2009 issue of the Journal of Nutrition ... that their pre-school children (2 to 5 years) had ...
... in the brain,s hippocampus, but what controls this birth has ... Science , neuroscientists at the Johns Hopkins University School ... which depends on brain activity, also depends on a protein ... genetic material. "How is it that when you ...
Cached Biology News:Carnegie Mellon to unveil new sequestration plan 2Eating habits and exercise behaviors in children can deteriorate early 2Growth of new brain cells requires 'epigenetic' switch 2
anti-dansyl, rabbit IgG fraction *1 mg/mL* Secondary Detection; Anti-Dye and Anti-Hapten Antibodies...
MOUSE ANTI RAT RT1Ac Immunogen: PHA activated rat lymphocytes...
Prepared in 0.85% saline....
TACS Apoptotic DNA Laddering Kits are used to assay cells and tissues for apoptosis by...
Biology Products: